1例PCI术后并发消化道出血患者的药学监护

Pharmaceutical Care for One Patient with PCI Complicated with Gastrointestinal Bleeding

消化道出血为冠状动脉介入治疗(PCI)术后较为常见的出血并发症,它会延长患者住院时间,增加心血管事件的发生率及死亡率,并且由于治疗矛盾可引起支架内血栓,进一步增加患者的死亡率。临床药师对1例PCI术后消化道出血患者实施药学监护,协助医师制定用药方案,针对患者消化道出血后抗栓与止血治疗矛盾及时调整用药方案,通过全程药学监护保障患者药物治疗的有效性和安全性,降低了冠脉血栓形成的风险,成功治愈了患者的消化道出血。

Gastrointestinal bleeding after pereutaneous coronary interention （PCI） is a common bleeding complication, which prolongs the time of hospitalization, increases the incidence of cardiovascular events and mortality, and causes thrombosis in stent due to the treatment Contradictions resulting in increased mortality. Clinical pharmacist participated in the medication treatment process of one patient with PCI complicated with gastrointestinal bleeding, performed individualized pharmaceutical care, and timely adjusted anticoagulant agents and antiplatelet drugs in the treatment of gastrointestinal bleeding. The therapeutic effect and medication safety of the pa- tient not only reduced the risk of coronary thrombosis, but also successfully cured the gastrointestinal bleeding.